FDA starts collecting Antigen Home Testing Kits data

the FDA has learnt that around 51,385 antigen home test kits have been sold in the last few months.

FDA State

Last Updated on January 17, 2022 by The Health Master

NAGPUR: Food and Drug Administration (FDA) Maharashtra has urged the registered pharmacists to update them about the records of the sales, purchases, and stocks of the antigen home testing kits in the backdrop of the state government’s expressing concern with the district and civic administration over the unregulated use and unreported cases aggravating the community transmission.

As on Thursday, the FDA has learnt that around 51,385 antigen home test kits have been sold in the last few months.

With no concrete data or records, FDA officials and other concerned authorities from civic and district administrations are now unsure how many of these tests have gone unreported or properly updated by the users on the Indian Council of Medical Research (ICMR) portals as per the written directions mentioned with the product.

According to a data accessed by TOI, one of the private agencies sold around 11,700 antigen home test kits in the entire December last year, while till January 12 this year, the sales figures have already crossed 11,186.

Since June last year, the agency has sold 38,800 home test kits, but there is no official data of whether the results have been updated on ICMR portals.

The FDA, awaiting the state guidelines, is now set to issue an advisory to the registered pharmacists to keep data, maintain records of the antigen do-it-yourself kits apart from the details of the purchasers.

The FDA is also set to ask the pharmacists to counsel the customers about the proper use, disposal and updation on the ICMR portal about the test result.

“As these home test kits are approved by the central drug regulatory body, it is still not clear how to regulate their sales, but we are conducting awareness for their proper use.

We are updating the pharmacists who would be expected to alert the customers regarding the norms,” said FDA assistant commissioner PM Ballal whose team under joint commissioner Viraj Paunikar would be taking the issue with the pharmacists.

Last week, the FDA started surveying the sale and use of the home testing kits following the intervention of divisional commissioner Prajakta Lavangare Verma.

C-19 task force member Dr Ravindra Sarnaik said the unregulated use of the home testing kits may lead to a parallel exponential growth in the numbers of cases that may explode without the official records getting updated about them.

Hetal Thakkar, secretary of the Nagpur district chemists and druggists association, said the pharmacists would extend support to the FDA to help spread words of awareness as unreported cases may lead to havoc.

Kerala DCA writes to NPPA to bring Kidney drug under DPCO

Pharma firms to install PNG run boilers to improve Air quality

Full marketing approval sought from DCGI for Covaxin

USFDA gives nod to Glenmark for Nasal Spray to treat allergic..

Narcotic Control Bureau seizes Drugs worth Rs 30 lakh

Big Pharma Companies buying land in Hyderabad

Govt warns against overuse, misuse of COVID medicines

BIS notifies new standard for these Medical Devices

Latest Notifications: Medical Devices

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner